Global Perspectives and Clinical Resources to Guide Treatment Decisions and Management of Adverse Events With BTK Inhibitor Therapy in CLL

Deepen your understanding of the optimal use of BTK inhibitors in CLL, including treatment strategies and managing potential AEs associated with these agents, through an expert-written text module with accompanying slides, a ClinicalThought commentary, and 2 interactive decision support tools—1 to support treatment decisions in CLL and another to support BTK inhibitor AE management.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC 

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca